Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-10-16

Clinical Trial Update: Human Behavioral Pharmacology Laboratory Study of Varenicline's Impact on Cocaine Reinforcement [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating varenicline for cocaine dependence has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varenicline (varenicline)

Snippet

Sponsor: Jennifer Plebani | Conditions: Cocaine Dependence | Phase 2 | Status: WITHDRAWN